agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
1.050
+0.159 (17.78%)
At close: Aug 13, 2025, 4:00 PM
0.9900
-0.0600 (-5.71%)
Pre-market: Aug 14, 2025, 9:13 AM EDT
agilon health Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for agilon health stock ranges from a low of $1.00 to a high of $8.50. The average analyst price target of $3.57 forecasts a 240.00% increase in the stock price over the next year.
Price Target: $3.57 (+240.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 14 | 13 | 14 | 14 | 13 | 13 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 19 | 21 | 21 | 20 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $4 → $1.5 | Strong Buy | Maintains | $4 → $1.5 | +42.86% | Aug 6, 2025 |
| Barclays | Barclays | Sell Maintains $3 → $1.5 | Sell | Maintains | $3 → $1.5 | +42.86% | Aug 6, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $3 → $1 | Strong Buy → Hold | Downgrades | $3 → $1 | -4.76% | Aug 6, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +185.71% | Jul 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +376.19% | May 13, 2025 |
Financial Forecast
Revenue This Year
6.01B
from 6.06B
Decreased by -0.83%
Revenue Next Year
6.62B
from 6.01B
Increased by 10.13%
EPS This Year
-0.35
from -0.63
EPS Next Year
-0.26
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3B | 7.6B | 9.3B | ||
| Avg | 6.0B | 6.6B | 7.9B | ||
| Low | 5.7B | 5.9B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.6% | 25.8% | 39.9% | ||
| Avg | -0.8% | 10.1% | 18.7% | ||
| Low | -5.7% | -2.0% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.13 | -0.06 | 0.02 | |
| Avg | -0.35 | -0.26 | -0.15 | |
| Low | -0.44 | -0.39 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.